cells form asymmetrical morphology to escape from their original location and invade into surrounding microenvironment. Various migration types can be broadly categorized into single-cell migration, multicellular streaming and collective migration, regulated by physical and molecular determinants of the cells and from stromal tissues [2] . Well-defined in vitro experiments have allowed precise delineation of the various cell migration mechanisms involving receptor-ligand interactions, but their complexity and synergistic effects of physical and molecular guiding principles make it still challenging to apparently identify the mechanisms [2, 3] . Furthermore, tumour cells have plasticity adaptively changing structure of ECM, invasion mode, and interaction with other cells by various extra-and intra-cellular mechanisms [2, 3] . Previous in vitro studies have failed revealing the complexity and plasticity, because they have regarded invaded tissue as a homogeneous and passive scaffold [2] . In the present study, we have considered the invaded tissue as heterogeneous ECM, a regulator of tumor cell behavior simultaneously allowing cancer cells to lead either proteolytic or non-proteolytic invasion [4] .
The ECM is generally classified into two main types: basement membrane and stromal/ interstitial matrix [5, 6] . Basement membrane is normally deposited beneath the epithelium as a thin and dense polymeric network with high tensile strength [6, 7] . As a reconstituted basement membrane, Matrigel extracted from the murine Engelbreth-Holm-Swarm (EHS) tumor has been widely used to study cancer cell invasion [8] . Stromal/interstitial matrices form the majority of connective tissues in the body and primarily comprise cross-linked collagen type I to impart 3-dimensional (3D) structural support [6, 9] . As a critical regulator of tumor progression [10] , ECMs, such as collagen type 1 and Matrigel, have been revealed to mediate malignant phenotype of breast cancer cells [11] . Several researchers have used the ECMs for migration studies of human breast cancer cells [12] and analyzed their interactions with cancer cell phenotypes [13] . However, there is an urgent requirement for technologies that permit quantified analysis and controlled perturbation of local cellular morphology and plasticity in various heterogeneous combinations of the ECMs in situ and in 3D while also allowing for chemotactic effects [14] .
In the present study, a novel and powerful microfluidic in vitro platform was applied to analyze the ability of a highly invasive human breast cancer cell line, MDA-MB-231, to invade 3D heterogeneous ECMs. The hydrogel-incorporating microfluidic platform includes the 3D ECM microenvironment of collagen type I, Matrigel, or their alignments and mixtures under gradient of fetal bovine serum (FBS) to compare the phenotypes of MDA-MB-231 cells, including morphology change, migration potential and plasticity. This platform enables high-resolution real-time and quantitative in situ analysis of cells cultured with ECM, facilitating interactions of these cells with 3D ECMs and the capture of complex behaviors occurring within the in vivo microenvironment [14] .
During the metastasis of breast cancer cells, they disrupt and interact with both ECMs (basement membrane and stromal matrix) in the early steps, escape from primary tumor aggregates and intravasate into the blood or lymphatic systems. We thought that ECMs additionally play an important role in cancer cell survival during and after extravasation (Figure 1a) . Here, we cultured MDA-MB-231 cells in a microfluidic platform (Figure 1b ) in which channels are connected by ECMs to mimic the ECM microenvironments surrounding tumor cells (pink, Figure 1c ) [15] . Collagen type I (COL) or Matrigel (MAT) was injected and gelled in the ECM region (pink). MDA-MB-231 cells (green beads) were seeded onto the ECMs in both center and bottom microfluidic channels in medium containing 1% FBS. After seeding, cell culture medium containing 5% FBS (blue) was introduced into the top channel, applying the FBS gradient on cells in the center channel, while cells in the channel below remained free from the gradient. The established gradient was simulated (Figure 1d ) considering diffusion of serum albumin protein in FBS in ECMs (D=6.10×10 -11 m 2 /s in collagen, D=6.41×10 -11 m 2 /s in matrigel; assuming molecular weight of serum albumin protein in FBS is 67 kDa [16] and diffusion through cells (D=10x10 -13 m 2 /s), with accuracy confirmed in our previous study [17] . In the simulated gradient profile, a steep FBS gradient (>3% per 50 microns) within hydrogel between the top and center channels was generated after 4 h and maintained over 24 h, while gradients across the hydrogel between the center and bottom channels were much smaller (control: <2% per 50 microns). Details of assay preparation and the molecular gradient presented in the legend to Supporting The ECM dependency of MDA-MB-231 in 3D morphology of invasion was supposed to be inherent, with a good consistency when they passed the interface between different ECMs. It was confirmed by heterogeneous alignment of COL and MAT in a microfluidic assay (Figure 3a ; details in Supporting Figure 5 ). MDA-MB-231 cells (green beads) seeded in a bottom channel onto hydrogel 1 (pink) invaded and passed through hydrogel 1 ( Figure 3b ) and finally invaded into hydrogel 2 (green). Interestingly, MDA-MB-231 cells showed dramatic morphological changes during passage through the interface of hydrogels, both from MAT (multicellualr) to COL (single) and COL (single) to MAT (multicellular) ( Figure  3c ). The findings validated the inherent plasticity of MDA-MB-231 morphology of invasion dependent on heterogeneous alignment of ECMs.
It suggested that cancer metastasis can be regulated not only by chemical stimuli but also by ECM compositions. In experiment with heterogeneous mixture of ECMs, we found that MDA-MB-231 cell morphology was regulated by a fraction of MAT in the MAT/COL mixture. SEM images of MAT, COL and MAT/COL mixtures are shown in Figure 3d . COL has fibril structure with pores through which MDA-MB-231 cells invade individually (Supporting Figure 6) . In dense mat-like MAT, MDA-MB-231 cells appear to invade by proteolytic ECM degradation, followed by microtracks [2] , which can easily be filled by followers (Supporting Figure 6 ). The microtracks explains multicellular invasion in MAT. Under the FBS gradient, the follower cells prefer proliferation in the microtrack to exploring a new route, as confirmed by the increased number of cells under the FBS gradient with no changes in stalk length (Figure 2c ). In correlation with the SEM images, the increased invasion area (Figure 3e ) and the sudden increase in cancer stalk length (Figure 3f ) suggest that proteolytic invasion of MAT and M3C1 induces multicellular invasion of MDA-MB-231. It shows that in a heterogeneous ECM condition, cancer cells can invade by various ways of morphological alteration and plasticity.
Can the heterogeneity of ECMs effectively affect metastasis? As shown in Figure 3e , ECM heterogeneity regulated morphological changes of cancer cells, but not the amount of invasion and metastatic potential. We supposed that additional factor of heterogeneous cell populations (mixed invasive and less (or non)-invasive cacner cells) would be required as an effective strategy for metastasis into a proteolytic matrix, because breast cancer is a heterogeneous disease, consisting of morphologically evident subtypes with variable molecular genetic signatures [18] . The invasion of non-invasive cancer cells into a proteolytic matrix was also proved by metastasis-suppressed cancer cells. Metalloproteinases (MMPs) are possible candidate factors for degradation of ECMs and might therefore play a critical role in the formation of microtracks by leading cells in MAT. It is widely accepted that the pleiotropic effect of MMPs has a significant effect on cancer cell growth in a secondary site 23 . However in 3D invasion into ECMs, MMP-inhibited MDA-MB-231 cells showed limited reduction of invasion area in COL, and no reduction in MAT. MMP-inhibited cells invading MAT still maintained multicellular stalk structures with leaders and microtracks (Supporting Figure 8) . Similar to the result of figure 4, we concluded that very limited population of the leaders (less-treated survivors or proliferated cancer cells) can induce invasion of MMP-inhibited (therefore non-or less-invasive) cells when they meet heterogeneous, proteolytically degrading ECMs.
The results demonstrates that plasticity of cancer cells is a very effective strategy for invasion into 3D proteolytic ECMs or ECMs with heterogeneous combinations. This might possibly explain the disappointing results of therapeutic approaches with inhibitors of MMPs in vivo 24 , but requires further investigation. We are additionally attempting to determine the internal mechanisms used by breast cancer cells to facilitate plasticity, in disrupting the basement membrane and migrating into the stromal matrix. Various molecular factors are currently under investigation with the developed method, including antiangiogenic and anti-metastatic factors. Cell-cell interactions that are tightly related to initial cell density and number of cells on/in hydrogels may be another key regulator of cancer cell morphology of invasion. Plasticity and reciprocity of breast cancer cells to various ECMs were quantitatively and 3-dimensionally analyzed in vitro and proved to be an effective strategy of metastasis with an invasion routes (i.e. microtracks) in heterogeneous ECMs.
Experimental Microfluidic device fabrication and preparation
Two of the microfluidic platforms used in this study were composed of 140 μm height channel-patterned PDMS (polydimethylsiloxane; Sylgard 184; Dow Chemical, MI) prepared on a SU-8 photoresist-patterned wafer (MicroChem, MA) using a conventional soft lithography process. Sterilized PDMS devices were bonded to glass coverslips with oxygen plasma (Femto Science, Korea) and coated with a PDL (poly-D-lysine hydrobromide; 1 mg/ml; Sigma-Aldrich, St Louis, MO) solution. Collagen type I (rat tail; cat. no. 40236; BD Bioscience), matrigel (Growth Factor Reduced (GFR) Matrigel™ Matrix, Phenol Red-free; BD Bioscience), and mixed hydrogel (collagen type I and matrigel at ratios of 1:1, 3:1 and 1:3) were used as the ECM scaffold material. Collagen type I was diluted to 2 mg/ml in 10× phosphate-buffered saline (PBS; Gibco) and gel stiffness controlled by altering the pH of collagen solution to 11 by adjusting the amount of 0.5N NaOH. The hydrogel scaffoldintroduced into the microfluidic channel was allowed to gel in a 5% CO 2 incubator at 37°C for 30 minutes. In the 3-gel device, hydrogel 1 was first injected into right and left gel scaffold regions, and after 30 minutes of incubation, hydrogel 2 or cells embedded in hydrogel 2 introduced into middle gel scaffold region, followed by incubation for 30 minutes. After gelation, all channels were filled with culture medium and plated in a humidified incubator before cell seeding. The hydrogel pH was irrelevant to cell morphology, since it was naturally neutralized by culture medium in the channels following gelation.
MDA-MB-231 breast cancer cell culture in microfluidic systems
The commercially available MDA-MB-231 human breast adenocarcinoma cell line was cultured in RPMI-1640 containing 10% fetal bovine serum (FBS). Cancer cells were seeded into cell culture channels of the microfluidic device by preparing suspensions at a density of 1×10 6 cells/ml, and the device maintained at 37°C in a 5% CO 2 incubator for 2 h in a tilted position to facilitate attachment of cells onto collagen and matrigel scaffold by gravity. RPMI-1640 containing 1% FBS (basic nutrient amount for cell culture in a microfluidic channel) was filled in the cell culture channels, and medium containing 5% FBS introduced into the condition channel to generate a gradient within the gel scaffold. For cells embedded in hydrogel, the cancer suspension was prepared at a concentration of 1×10 7 cells/ml diluted 1/10 times to obtain a desired concentration of 1×10 6 cells/ml. An aliquot of cell suspension (20 μl) was mixed in 200 μl gel and filled into the middle gel scaffold region. All microfluidic channels were filled with medium containing 5% FBS. Media in all channels were exchanged with fresh medium every day to maintain the linear concentration gradient. Approximately 50∼60 μl of medium was needed in each reservoir (100∼120 μl per channel) at the inlets and outlets to minimize medium evaporation from the channels.
MDA-MB-231 and MCF-7 cell co-culture in microfluidic systems
MCF-7 breast cancer cell line was cultured in 1640 RPMI containing 10% FBS and seeded into the cell culture channels by preparing suspensions at a density of 1×10 6 cells/ml, and the device maintained at 37°C in a 5% CO 2 incubator for 2 h in a tilted position. Then, 1×10 6 cells/ml of MDA-MB-231 cells were additionally seeded into the same cell culture channels and cultured in a tilted position for 2 h. RPMI-1640 containing 1% FBS and 5% FBS was filled in the cell culture channels in the same way described in "MDA-MB-231 breast cancer cell culture in microfluidic systems".
COMSOL simulation of the FBS diffusion gradient profile
The chemical gradient generated within hydrogel was simulated using COMSOL Multiphysics 4.0 (COMSOL Inc., MA, USA). We assumed that the diffusion coefficient of FBS in culture medium was 4.28×10 -11 m 2 /s, and 6.10×10 -11 m 2 /s and 6.41×10 -11 m 2 /s in collagen and matrigel scaffold, respectively. Moreover, the concentrations of 5% FBS and 1% FBS in media were taken as 5×10 -3 mol/m 3 and 1×10 -2 mol/m 3 , respectively.
Quantification of 3D cell invasion and migration
The morphologies of migrating and invading cancer cells were monitored using phasecontrast microscopy (Olympus) every day before medium exchange. Fluorescent images were obtained by fixing cells with 4% paraformaldehyde for 15 minutes and permeabilizing with 0.1% Triton X-100 for 5 minutes at room temperature. Actin filaments and nuclei were stained with rhodamine-phalloidin (Sigma-Aldrich) and DAPI (40,6-diamidino-2-phenylindole; Sigma-Aldrich) for 1 hour, respectively. Also, MCF-7 and MDA-MB-231 cells were blocked 4% (wt/vol) bovine serum albumin (BSA) and incubated with anti-Ecadherin (1:100, Santa Cruz Biotechnology, inc.) and CD44 (5 μl antibody/1×10 6 cells, Invitrogen) overnight at 4°C. Cells were washed with PBS and incubated with Alexa 488-conjugated goat anti-rabbit antibody (1:200, Molecular Probes®). Scale bar: 500nm. Quantification graphs of (e) area fraction and (f) total length of cancer stalks of MDA-MB-231 invading hydrogel generated with various mixing ratios of MAT and COL under 5% FBS and control. Total n=44, and error bars indicate mean values ± standard error (*P < 0.05; **P < 0.01; ***P < 0.001). 
